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Common variable immune deﬁciency (CVID) is the most com-
mon primary immune deﬁciency in adults and children, and is
characterized by reduced or absent antibody production along
with reduced serum levels of immunoglobulins, IgG, IgA, and/or
IgM.1 The main manifestation of this disease is recurrent infections.
However CVID is known to have a heterogeneous phenotype2 and
is associated with multiple autoimmune conditions such as hemo-
lytic anemia, immune thrombocytopenic purpura, rheumatoid
arthritis, systemic lupus, inﬂammatory bowel disease (IBD) and
also multiple autoimmune liver conditions.2,3 The most commonly
reported liver diseases in CVID include viral hepatitis, nodular
regenerative hyperplasia (NRH), primary biliary cirrhosis and auto-
immune hepatitis.3e5 Primary sclerosing cholangitis (PSC) is
another form of autoimmune liver disease with a heterogeneous
presentation characterized by chronic inﬂammation of the biliary
epithelium resulting in chronic cholestasis and multifocal bile
duct strictures.6 This disease can affect the entire biliary tree and
lead to ﬁbrosis of the hepatic parenchyma and biliary system,
ending in cirrhosis and malignancy.7
Herein we report two cases of PSC associated with CVID. To our
knowledge, this is the ﬁrst report of such association in literature.Case 1
The ﬁrst case is a 66-year-old male who had been in good state
of health until age 45 when he developed diarrhea and was diag-
nosed with Ulcerative Colitis (UC) after a colonoscopy with bi-
opsies at another hospital. His UC remained quiescent on oral 5-
ASA. At age 50, he developed pruritus and elevated liver enzymes.
Viral hepatitis markers were all reported negatives. After a com-
plete work up including imaging, Endoscopic Retrograde Cholan-
giopancreatography (ERCP) (Fig. 1) and liver biopsy, he was
diagnosed with PSC. PSC progressed over the course of 4 years
and the patient underwent successful liver transplant for end
stage liver disease. Additionally the patient had history of recur-
rent urinary tract infections, C. difﬁcile colitis, basal cell carcinoma
on face, and skin melanomas on scalp and thigh. His UC was under
control for almost 10 years until he developed persistent diarrhea.
He underwent colonoscopy and biopsy that were reported with no
pathological changes. No improvement in diarrhea was achieved
by changing his transplant medication including discontinuation
of the sirolimus. Of note, patient experienced two episodes ofPeer review under responsibility of Japanese Society of Allergology.
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mune work up at that time showed low immunoglobulin titers;
IgG of 276 mg/dL (normal range 694e1618 mg/dL), IgA 45 mg/dL
(normal range 81e463 mg/dL), and IgM <5 mg/dL (normal range
48e271 mg/dL). He was referred to Northwestern immunology
clinic for work up at this stage. We could trace back most of his
past laboratory work up and could ﬁnd another set of Immuno-
globulin titers checked one year prior to the liver transplant that
showed hypogammaglobulinemia of IgG 467 mg/dL, IgA 72 mg/
dL and IgM <17 mg/dL. An infection cause could not be found
despite extensive work up for chronic diarrhea. Immunologic
studies showed no response to vaccination against pneumococcal
disease. Further investigation for hypogammaglobulinemia
including protein-losing syndromes was negative; subsequently
patient was diagnosed with CVID. He was found to have diffuse
bronchiectasis on high resolution CT scan of lungs. Patient was
placed on monthly injections of Intravenous immunoglobulin
(IVIG) at that point, and no infections have been reported in 1.5
year follow up.Case 2
The second case is a 29-year-old female who had recurrent sino-
pulmonary infections since childhood. At age 11, she was found to
have bronchiectasis in the setting of recurrent lung infections and
eventually at age 15 was diagnosed with CVID and was placed on
IVIG. She continued to have multiple episodes of sinus infections,
giardia infections and urinary tract infections. She was hospitalized
for pneumonia several times, and also needed sinus surgery for
recurrent pansinusitis unresponsive to chronic medical therapy.
She had no response to pneumococcal vaccination. Like our ﬁrst
case, she developed pruritus and fatigue but at a younger age of
25. Her liver enzymes were elevated with alkaline phosphatase of
1820 mg/dL, ALT of 119 units/L, AST of 81 units/L and total bilirubin
of 3.4 mg/dL. She had a complete work up and was diagnosed with
PSC by Magnetic Resonance Cholangiopancreatogram (MRCP) and
liver biopsy. Repeat MRCP in following years showed progression
of PSC and her pruritus continued. Due to the extensive lung dam-
age including diffuse bronchial wall thickening, bronchiectasis and
bronchiolectasis throughout both lungs she could not tolerate a
liver transplant surgery and is currently under evaluation for dou-
ble lung/liver transplant.
Liver diseases are reported in a signiﬁcant percentage of patients
with CVID. In one study 12% of cases with CVID had evidence of
liver disease.3 These abnormalities have been attributed to a broad
spectrum of diseases. In past, the most common cause of hepatitisevier B.V. All rights reserved.
Fig. 1. A: ERCP picture of Case 1 showing localized areas of dilatation proximal to biliary strictures (arrows) indicative of PSC. B: MRCP image of Case 1 showing multiple strictures
(arrows) followed by dilatation in intrahepatic ducts indicative of PSC.
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noglobulin infusions.4 Another commonly reported liver disease in
CVID that has been describedmore recently is nodular regenerative
hyperplasia, which in some cases was associated with autoimmune
hepatitis like disease.5,8 Furthermore some other forms of autoim-
mune liver diseases including primary biliary cirrhosis and autoim-
mune hepatitis have been reported in CVID.3 However we could not
ﬁnd any previous report of PSC in patients with CVID in the
literature.
In case one the patient also suffers fromUC. Inﬂammatory bowel
disease (IBD), in particular UC is long known to be associated with
PSC, and is reported in about two third of patients with PSC.9 On the
other hand, the intestinal pathologies are fairly common in CVID
patients and range from inﬂammatory bowel-like disease to
sprue-like lesions of the small intestine leading to diarrhea.10 The
only curative treatment for complicated PSC is liver transplant.6
This, however, in CVID patients could be limited by severely
compromised lung function in the setting of extensive bronchiec-
tasis. Thus, in CVID patients, earlier diagnosis of PSC and timely
liver transplantation before progression of any ensuing lung dam-
age should be taken into consideration.
Aside from cirrhosis and liver failure, PSC is strongly associated
with cholangiocarcinoma, and also colon cancer in presence of
concomitant IBD.6 These patients need to undergo immediate
screenings at diagnosis (Ultrasonography, ERCP and colonoscopy)
followed by an annual surveillance program to detect any evi-
dence of the aforementioned malignancies at earlier stages. There-
fore early diagnosis of PSC is crucial to start prompt
implementation of cancer screening. This is even more clinically
relevant in patients with CVID who are already at higher risk of
cancer in general11 and gastrointestinal malignancies in partic-
ular.12e14 This is important in the view of frequently reported
gastrointestinal symptoms by CVID patients that could mask the
early manifestations of GI cancers.15
We report two cases of primary sclerosing cholangitis in pa-
tients with CVID. The diagnosis of PSC should be considered
when taking care of CVID patients who have evidence of liver dis-
ease. Early detection of PSC in CVID will help in timely implemen-
tation of liver transplantation prior to any potential lung sequel
associated with CVID, and employment of cancer screenings and
surveillances for the associated malignancies, leading to an overall
better outcome of the patient.Conﬂict of interest
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